AI platform accelerating therapies for rare & inflammatory diseases.
GEn1E Lifesciences is a clinical-stage biotechnology company focused on developing first-in-class precision therapies for inflammatory and rare diseases. The company aims to expedite the drug development process, having successfully advanced from early discovery to Phase 2 clinical trials in just 2.5 years, utilizing seed capital to support its initiatives. GEn1E's primary therapeutic candidates target kinase dysregulation, which is a significant contributor to various inflammatory diseases, and the company has established a pipeline that includes multiple programs at different stages of devel…